Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: the PSERENADE project.
Yang Y, Knoll MD, Herbert C, Bennett JC, Feikin DR, Quesada MG, Hetrich MK, Zeger SL, Kagucia EW, Xiao M, Cohen AL, van der Linden M, du Plessis M, Yildirim I, Winje BA, Varon E, Valenzuela MT, Valentiner-Branth P, Steens A, Scott JA, Savrasova L, Sanz JC, Khan AS, Oishi K, Nzoyikorera N, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mackenzie GA, MacDonald L, Ladhani SN, Kristinsson KG, Kleynhans J, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Hammitt LL, Guevara M, Gilkison C, Gierke R, Desmet S, De Wals P, Dagan R, Colzani E, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Ampofo K, O'Brien KL, Hayford K; PSERENADE Team. Yang Y, et al. Among authors: kagucia ew. J Infect. 2025 Jan 24:106426. doi: 10.1016/j.jinf.2025.106426. Online ahead of print. J Infect. 2025. PMID: 39864526
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.
Coldiron ME, Soumana I, Baudin E, Langendorf C, Mamiafo Tchoula C, Brah S, Karani A, Gallagher KE, Kagucia EW, Scott JAG, Grais RF. Coldiron ME, et al. Among authors: kagucia ew. Lancet Infect Dis. 2025 Jan 8:S1473-3099(24)00719-9. doi: 10.1016/S1473-3099(24)00719-9. Online ahead of print. Lancet Infect Dis. 2025. PMID: 39798587
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.
Bennett JC, Deloria Knoll M, Kagucia EW, Garcia Quesada M, Zeger SL, Hetrich MK, Yang Y, Herbert C, Ogyu A, Cohen AL, Yildirim I, Winje BA, von Gottberg A, Viriot D, van der Linden M, Valentiner-Branth P, Suga S, Steens A, Skoczynska A, Sinkovec Zorko N, Scott JA, Savulescu C, Savrasova L, Sanz JC, Russell F, Ricketson LJ, Puentes R, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, MacDonald L, Lepp T, Ladhani SN, Kristinsson KG, Kozakova J, Klein NP, Jayasinghe S, Ho PL, Hilty M, Heyderman RS, Hasanuzzaman M, Hammitt LL, Guevara M, Grgic-Vitek M, Gierke R, Georgakopoulou T, Galloway Y, Diawara I, Desmet S, De Wals P, Dagan R, Colzani E, Cohen C, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Bigogo G, Ampofo K, O'Brien KL, Feikin DR, Hayford K; PSERENADE Team. Bennett JC, et al. Among authors: kagucia ew. Lancet Infect Dis. 2024 Dec 17:S1473-3099(24)00665-0. doi: 10.1016/S1473-3099(24)00665-0. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39706204 Free article.
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.
Lucinde RK, Gathuri H, Isaaka L, Ogero M, Mumelo L, Kimego D, Mbevi G, Wanyama C, Otieno EO, Mwakio S, Saisi M, Isinde E, Oginga IN, Wachira A, Manuthu E, Kariuki H, Nyikuli J, Wekesa C, Otedo A, Bosire H, Okoth SB, Ongalo W, Mukabi D, Lusamba W, Muthui B, Adembesa I, Mithi C, Sood M, Ahmed N, Gituma B, Giabe M, Omondi C, Aman R, Amoth P, Kasera K, Were F, Nganga W, Berkley JA, Tsofa B, Mwangangi J, Bejon P, Barasa E, English M, Scott JAG, Akech S, Kagucia EW, Agweyu A, Etyang AO. Lucinde RK, et al. Among authors: kagucia ew. BMC Infect Dis. 2024 Nov 5;24(1):1246. doi: 10.1186/s12879-024-10140-6. BMC Infect Dis. 2024. PMID: 39501217 Free PMC article.
Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.
Carcelen AC, Kong AC, Takahashi S, Hegde S, Jaenisch T, Chu M, Rochford R, Kostandova N, Gurley ES, Wesolowski A, Azman AS, van der Klis FRM, den Hartog G, Drakeley C, Heaney CD, Winter AK, Salje H, Rodriguez-Barraquer I, Leung DT, Njenga SM, Kagucia EW, Jambo KC, Wolter N, Charles RC, Saboyá-Díaz MI, Martin DL, Moss WJ. Carcelen AC, et al. Among authors: kagucia ew. Am J Trop Med Hyg. 2024 Sep 3;111(5):1145-1152. doi: 10.4269/ajtmh.24-0296. Print 2024 Nov 6. Am J Trop Med Hyg. 2024. PMID: 39226906 Free PMC article.
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study.
Otiende M, Nyaguara A, Bottomley C, Walumbe D, Mochamah G, Amadi D, Nyundo C, Kagucia EW, Etyang AO, Adetifa IMO, Brand SPC, Maitha E, Chondo E, Nzomo E, Aman R, Mwangangi M, Amoth P, Kasera K, Ng'ang'a W, Barasa E, Tsofa B, Mwangangi J, Bejon P, Agweyu A, Williams TN, Scott JAG. Otiende M, et al. Among authors: kagucia ew. Nat Commun. 2023 Oct 28;14(1):6879. doi: 10.1038/s41467-023-42615-6. Nat Commun. 2023. PMID: 37898630 Free PMC article.
Symptom prevalence and secondary attack rate of SARS-CoV-2 in rural Kenyan households: A prospective cohort study.
Gallagher KE, Nyiro J, Agoti CN, Maitha E, Nyagwange J, Karani A, Bottomley C, Murunga N, Githinji G, Mutunga M, Ochola-Oyier LI, Kombe I, Nyaguara A, Kagucia EW, Warimwe G, Agweyu A, Tsofa B, Bejon P, Scott JAG, Nokes DJ. Gallagher KE, et al. Among authors: kagucia ew. Influenza Other Respir Viruses. 2023 Sep;17(9):e13185. doi: 10.1111/irv.13185. Influenza Other Respir Viruses. 2023. PMID: 37752066 Free PMC article.
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Kagucia EW, Ziraba AK, Nyagwange J, Kutima B, Kimani M, Akech D, Ng'oda M, Sigilai A, Mugo D, Karanja H, Gitonga J, Karani A, Toroitich M, Karia B, Otiende M, Njeri A, Aman R, Amoth P, Mwangangi M, Kasera K, Ng'ang'a W, Voller S, Ochola-Oyier LI, Bottomley C, Nyaguara A, Munywoki PK, Bigogo G, Maitha E, Uyoga S, Gallagher KE, Etyang AO, Barasa E, Mwangangi J, Bejon P, Adetifa IMO, Warimwe GM, Scott JAG, Agweyu A. Kagucia EW, et al. Influenza Other Respir Viruses. 2023 Sep;17(9):e13173. doi: 10.1111/irv.13173. Influenza Other Respir Viruses. 2023. PMID: 37752065 Free PMC article.
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys.
Gallagher KE, Adetifa IMO, Mburu C, Bottomley C, Akech D, Karani A, Pearce E, Wang Y, Kagucia EW, Goldblatt D, Hammitt LL, Scott JAG. Gallagher KE, et al. Among authors: kagucia ew. Lancet Infect Dis. 2023 Nov;23(11):1291-1301. doi: 10.1016/S1473-3099(23)00206-2. Epub 2023 Jul 7. Lancet Infect Dis. 2023. PMID: 37429307 Free PMC article.
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
Public Health Collaborators on Serosurveillance for Pandemic Preparedness and Response PHSeroPPR. Public Health Collaborators on Serosurveillance for Pandemic Preparedness and Response PHSeroPPR. Lancet. 2023 Jul 29;402(10399):356-358. doi: 10.1016/S0140-6736(23)00964-9. Epub 2023 May 26. Lancet. 2023. PMID: 37247625 Free PMC article. No abstract available.
39 results